News

Find News

Filter articles

Showing 3131 to 3140 of 3417 results

Pfizer and Mylan reach Celebrex agreement

US02-06-2014Legal developments

Pfizer and Mylan have agreed to settle litigation related to arthritis treatment Celebrex (celecoxib), Mylan announced today, June 2.

Turkish company causes row over ‘pharmacist’ trademark

Turkey29-05-2014

A pharmaceutical company in Turkey has run into trouble after attempting to register the Turkish word for ‘pharmacist’ as a trademark.

EPO upholds Copaxone patent

EU28-05-2014

Teva has successfully defended a patent for its multiple sclerosis drug Copaxone (glatiramer acetate) in Europe.

Genentech refused appeal in Herceptin case

UK27-05-2014Legal developments

Justice Colin Birss has refused Roche’s biotechnology subsidiary Genentech the permission to appeal against an English High Court decision in which two patents covering its blockbuster breast cancer drug, Herceptin (trastuzumab), were revoked.

Acura ends all Aversion litigation with final Sandoz settlement

US23-05-2014Legal developments

US-based drug company Acura and Novartis’s generic arm Sandoz have settled their patent infringement dispute related to an abuse-deterrent formulation of the painkiller Aversion (oxycodone).

Mylan quashes morning-after pill dosage patent

UK22-05-2014Legal developments

Generics (UK) Limited, the UK arm of Mylan, has succeeded in invalidating a patent held by Hungarian pharmaceutical company Richter Gedeon at the English High Court.

Medtronic and Edwards settle heart valve litigation

US21-05-2014Legal developments

Medical device rivals Medtronic and Edwards Lifesciences have agreed to settle all patent litigation, including cases related to transcatheter heart valves.

UNDP urges use of competition law to boost healthcare access

20-05-2014

The United Nations Development Programme has released a guidebook for low- to middle- income countries on how to increase access to essential health technologies and HIV treatments by using competition law and policy.

US court denies Teva’s final shot at blocking Copaxone copies

US19-05-2014Legal developments

A US district court has dismissed Teva’s case against the FDA aimed at stopping the administration from approving generic versions of its blockbuster multiple sclerosis drug Copaxone (glatiramer acetate).

Lilly’s Alimta dosage patent invalidated at English High Court

UK16-05-2014Legal developments

The English High Court has ruled that a patent covering vitamin dosage regimens for Eli Lilly’s lung cancer drug Alimta (pemetrexed disodium) would not be infringed by generic competitors.

Showing 3131 to 3140 of 3417 results

LSIPR